Collagen-povidone for Diabetic Seniors' Tenosynovitis

Instituto Mexicano del Seguro Social

Status and phase: Completed; Phase 4

Conditions: Diabetes Complications

Treatments: Drug: collagen-povidone solution

Study type: Interventional

Funder types: Other

Identifiers

NCT06396819

Collagen-Polyvidone-24

Details and patient eligibility

About

Diabetes affects 415 million adults globally, leading to hand issues. Povidone collagen shows promise in managing tenosynovitis. A clinical trial was conduced to compared its efficacy in adults over 60. It is shown that the intervention reduces pain, improves functionality, and grip strength with no complications. Collagen povidone holds potential for treating diabetic hand issues.

Full description

A randomized clinical trial from January 2022 to January 2023 compared povidone collagen intervention with a placebo in adults aged 60 and above suffering from stenosing tenosynovitis. Participants were randomized into Case (collagen-povidone) and Control (physiological solution) groups. The study evaluated parameters like tenosynovitis, diabetes, pain, functionality, and grip strength.

Enrollment: 25 patients

Sex: All

Ages: 60+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Diagnostic of stenosing tenosynovitis
• Diagnostic of diabetes
• Adults aged 60 or older

Exclusion criteria

• Adults aged 60 or older

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Single Blind

---

25 participants in 2 patient groups, including a placebo group

Therapeutic intervention using povidone collagen

Experimental group

Treatment:

Drug: collagen-povidone solution

Therapeutic intervention using placebo

Placebo Comparator group

Treatment:

Drug: collagen-povidone solution